Minerva Neurosciences, Inc. (NERV) stock

NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30

$2.30−0.08 (-3.36%)

Close on Nov 13, 2026Market cap $109.82MP/E –Yield –

Minerva Neurosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Minerva Neurosciences's EV/EBITDA was 2.9× on Jun 30, 2021.

Period	Period end	Value	Change (pts)
2021	Jun 30, 2021	2.9×	–

See a number that looks wrong?